UBS raised the firm’s price target on Cryoport (CYRX) to $12.50 from $11 and keeps a Buy rating on the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
- Positive Outlook for CryoPort Amid Strong Revenue Growth and Resurgent Demand
- CryoPort’s Strong Q3 Performance and Future Growth Potential Justify Buy Rating and Increased Price Target
- Cryoport Reports Strong Q3 2025 Revenue Growth
- Cryoport reports Q3 EPS (18c), consensus (19c)
- Cryoport raises FY25 revenue view to $170.0M-$174.0M from $165M-$172M